Close Close
Popular Financial Topics Discover relevant content from across the suite of ALM legal publications From the Industry More content from ThinkAdvisor and select sponsors Investment Advisor Issue Gallery Read digital editions of Investment Advisor Magazine Tax Facts Get clear, current, and reliable answers to pressing tax questions
Luminaries Awards

Life Health > Health Insurance > Your Practice

Leahy Seeks Antitrust Waiver Repeal

Your article was successfully shared with the contacts you provided.

WASHINGTON–The chairman of the Senate Judiciary Committee has introduced legislation that would repeal the antitrust waiver provided under the McCarran-Ferguson Act for health insurance and medical malpractice insurance companies.

The bill is an apparent attempt to pressure the health insurance industry as well as Republicans in Congress to support health care reform legislation now being pushed in Congress by Democrats and the Obama administration.

“A few industries have used their influence to obtain a special, statutory exemption from the antitrust laws, and the insurance industry is one of them,” Sen. Patrick Leahy, D-Vt., said in introducing the legislation. “In the markets for health insurance and medical malpractice insurance, patients and doctors are paying the price, as costs continue to increase at an alarming rate. Insurers should not object to being subject to the same antitrust laws as everyone else.”

Leahy said provisions of the Health Insurance Industry Antitrust Enforcement Act he introduced would repeal the federal antitrust exemption for health insurance and medical malpractice insurance companies for what he called “flagrant antitrust violations,” including price-fixing, bid-rigging and market allocations.

As a result of his bill, health insurers and medical malpractice insurers would be subject to the same laws regulating competition that apply to almost every other company doing business in the U.S., Sen. Leahy argued.


© 2024 ALM Global, LLC, All Rights Reserved. Request academic re-use from All other uses, submit a request to [email protected]. For more information visit Asset & Logo Licensing.